Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP996102.RAHEla_udaNo4f4UzmidqG1wUSU2btW0Wkbe8ibqi85d0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP996102.RAHEla_udaNo4f4UzmidqG1wUSU2btW0Wkbe8ibqi85d0130_assertion type Assertion NP996102.RAHEla_udaNo4f4UzmidqG1wUSU2btW0Wkbe8ibqi85d0130_head.
- NP996102.RAHEla_udaNo4f4UzmidqG1wUSU2btW0Wkbe8ibqi85d0130_assertion description "[Prompted by this finding and because RAS/RAF/MEK mutations are known mediators of acquired resistance in other solid tumors (colon cancers, gastrointestinal stromal tumors, and melanomas) responsive to targeted therapies, we analyzed the frequency of secondary KRAS/NRAS/BRAF/MEK1 gene mutations in the largest collection to date of lung cancers with acquired resistance to EGFR TKIs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP996102.RAHEla_udaNo4f4UzmidqG1wUSU2btW0Wkbe8ibqi85d0130_provenance.
- NP996102.RAHEla_udaNo4f4UzmidqG1wUSU2btW0Wkbe8ibqi85d0130_assertion evidence source_evidence_literature NP996102.RAHEla_udaNo4f4UzmidqG1wUSU2btW0Wkbe8ibqi85d0130_provenance.
- NP996102.RAHEla_udaNo4f4UzmidqG1wUSU2btW0Wkbe8ibqi85d0130_assertion SIO_000772 22773810 NP996102.RAHEla_udaNo4f4UzmidqG1wUSU2btW0Wkbe8ibqi85d0130_provenance.
- NP996102.RAHEla_udaNo4f4UzmidqG1wUSU2btW0Wkbe8ibqi85d0130_assertion wasDerivedFrom befree-2016 NP996102.RAHEla_udaNo4f4UzmidqG1wUSU2btW0Wkbe8ibqi85d0130_provenance.
- NP996102.RAHEla_udaNo4f4UzmidqG1wUSU2btW0Wkbe8ibqi85d0130_assertion wasGeneratedBy ECO_0000203 NP996102.RAHEla_udaNo4f4UzmidqG1wUSU2btW0Wkbe8ibqi85d0130_provenance.